World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
119
Citations
49173
World Ranking
3914
National Ranking
2142

Matthew T. Roe publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Matthew T. Roe sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 756 publications — 85th percentile

85% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Matthew T. Roe D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Matthew T. Roe sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 119 D-Index — 81st percentile

81% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Matthew T. Roe is affiliated with Duke University in the United States and has contributed extensively to the field of medicine, particularly focusing on cardiology and cardiovascular medicine. Their body of work includes a significant number of publications, with a concentration in areas such as antiplatelet therapy and cardiovascular diseases, acute myocardial infarction research, and health systems, economic evaluations, and quality of life.

Among the recent papers authored or co-authored by Matthew T. Roe are:

  • Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease, 2021, published in New England Journal of Medicine
  • The Role of Machine Learning in Clinical Research: Transforming the Future of Evidence Generation, 2021, published in Trials
  • Targeting Vascular Calcification in Chronic Kidney Disease, 2020, published in JACC Basic to Translational Science
  • Cardiovascular Safety of Degarelix Versus Leuprolide in Patients With Prostate Cancer: The Primary Results of the PRONOUNCE Randomized Trial, 2021, published in Circulation
  • Risk Factor Burden and Long-Term Prognosis of Patients With Premature Coronary Artery Disease, 2020, published in Journal of the American Heart Association

The scientist frequently collaborates with a core group of co-authors, including Adrian F. Hernandez, W. Schuyler Jones, Robert A. Harrington, Mark B. Effron, and Kamal Gupta. These collaborations have contributed to a series of publications across several prominent medical journals.

Matthew T. Roe's research is frequently published in the following venues:

  • Circulation
  • Journal of the American Heart Association
  • UNC Libraries
  • The Journal of Urology
  • The American Journal of Cardiology

The main field of study for Matthew T. Roe is Medicine, with 90 related publications. Subfields include clinical and research areas such as:

  • Cardiology and Cardiovascular Medicine
  • Surgery
  • Economics and Econometrics
  • Endocrinology, Diabetes and Metabolism
  • Nephrology

Specific topics within Matthew T. Roe's work cover multiple aspects of cardiovascular and metabolic health, including:

  • Antiplatelet Therapy and Cardiovascular Diseases
  • Acute Myocardial Infarction Research
  • Health Systems, Economic Evaluations, Quality of Life
  • Diabetes Treatment and Management
  • Cardiovascular Function and Risk Factors
  • Machine Learning in Healthcare
  • Coronary Interventions and Diagnostics

This profile reflects a comprehensive research footprint across clinical trials, disease mechanisms, and applied technologies in healthcare, contributing data and insights relevant to both cardiovascular medicine and broader medical fields.

Best Publications

  • Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial

    Adrian F Hernandez;Jennifer B Green;Salim Janmohamed;Ralph B D'Agostino

  • Baseline Risk of Major Bleeding in Non–ST-Segment–Elevation Myocardial Infarction The CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA guidelines) Bleeding Score

    Sumeet Subherwal;Richard G. Bach;Anita Y. Chen;Brian F. Gage

  • Prasugrel versus clopidogrel for acute coronary syndromes without revascularization

    Matthew T. Roe;Paul W. Armstrong;Keith A.A. Fox;Harvey D. White

  • Gender disparities in the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes: large-scale observations from the CRUSADE (Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes With Early Implementation of the American College of Cardiology/American Heart Association Guidelines) National Quality Improvement Initiative.

    Andra L. Blomkalns;Anita Y. Chen;Judith S. Hochman;Eric D. Peterson

  • Association between hospital process performance and outcomes among patients with acute coronary syndromes.

    Eric D. Peterson;Matthew T. Roe;Jyotsna Mulgund;Elizabeth R. DeLong

  • Trends in the Prevalence and Outcomes of Radial and Femoral Approaches to Percutaneous Coronary Intervention A Report From the National Cardiovascular Data Registry

    Sunil V. Rao;Fang Shu Ou;Tracy Y. Wang;Matthew T. Roe

  • Excess Dosing of Antiplatelet and Antithrombin Agents in the Treatment of Non-ST-Segment Elevation Acute Coronary Syndromes

    Karen P. Alexander;Anita Y. Chen;Matthew T. Roe;L. Kristin Newby

  • Sex differences in mortality following acute coronary syndromes.

    Jeffrey S. Berger;Laine Elliott;Dianne Gallup;Matthew Roe

  • Utilization of early invasive management strategies for high-risk patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE Quality Improvement Initiative

    Deepak L. Bhatt;Matthew T. Roe;Eric D. Peterson;Yun Li

  • Use of Evidence-Based Therapies in Short-Term Outcomes of ST-Segment Elevation Myocardial Infarction and Non–ST-Segment Elevation Myocardial Infarction in Patients With Chronic Kidney Disease A Report From the National Cardiovascular Data Acute Coronary Treatment and Intervention Outcomes Network Registry

    Caroline S. Fox;Paul Muntner;Anita Y. Chen;Karen P. Alexander

  • Effect of alirocumab, a monoclonal antibody to PCSK9, on long-term cardiovascular outcomes following acute coronary syndromes: Rationale and design of the ODYSSEY Outcomes trial

    Gregory G. Schwartz;Laurence Bessac;Lisa G. Berdan;Deepak L. Bhatt

  • Treatments, trends, and outcomes of acute myocardial infarction and percutaneous coronary intervention.

    Matthew T. Roe;John C. Messenger;William S. Weintraub;Christopher P. Cannon

  • Patient Satisfaction and Its Relationship With Clinical Quality and Inpatient Mortality in Acute Myocardial Infarction

    Seth William Glickman;William Boulding;Matthew Manary;Richard Staelin

  • Contemporary Mortality Risk Prediction for Percutaneous Coronary Intervention: Results from 588,398 Procedures in the National Cardiovascular Data Registry

    Eric D. Peterson;David Dai;Elizabeth R. DeLong;J. Matthew Brennan

  • Pay for performance, quality of care, and outcomes in acute myocardial infarction.

    Seth W. Glickman;Fang Shu Ou;Elizabeth R. DeLong;Matthew T. Roe

  • Effect of lipid-lowering therapy on early mortality after acute coronary syndromes: an observational study

    Herbert D Aronow;Eric J Topol;Matthew T Roe;Penny L Houghtaling

  • Evolution in cardiovascular care for elderly patients with non-ST-segment elevation acute coronary syndromes: Results from the CRUSADE National Quality Improvement Initiative

    Karen P. Alexander;Matthew T. Roe;Anita Y. Chen;Barbara L. Lytle

  • Effect of Alirocumab on Lipoprotein(a) and Cardiovascular Risk After Acute Coronary Syndrome.

    Vera A. Bittner;Michael Szarek;Philip E. Aylward;Deepak L. Bhatt

  • Shifting the open-artery hypothesis downstream: the quest for optimal reperfusion.

    Matthew T Roe;E.Magnus Ohman;Arthur C.P Maas;Robert H Christenson

  • Sex Differences in Major Bleeding With Glycoprotein IIb/IIIa Inhibitors Results From the CRUSADE (Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes With Early Implementation of the ACC/AHA Guidelines) Initiative

    Karen P. Alexander;Anita Y. Chen;L. Kristin Newby;Janice B. Schwartz

Frequent Co-Authors

E. Magnus Ohman
E. Magnus Ohman Duke University
Eric D. Peterson
Eric D. Peterson The University of Texas Southwestern Medical Center
W. Brian Gibler
W. Brian Gibler University of Cincinnati
Robert A. Harrington
Robert A. Harrington Cornell University
Karen P. Alexander
Karen P. Alexander Duke University
Harvey D. White
Harvey D. White Auckland City Hospital
Deepak L. Bhatt
Deepak L. Bhatt Mount Sinai Hospital
Charles V. Pollack
Charles V. Pollack Thomas Jefferson University
Paul W. Armstrong
Paul W. Armstrong University of Alberta
L. Kristin Newby
L. Kristin Newby Duke University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in Medicine doesn't just mean medical school—online nursing programs are a flexible option for many students. With the growth of virtual learning, prospective healthcare professionals can now earn degrees such as RN to BSN, nurse practitioner, or even a PhD in nursing education remotely.

One of the most common questions is how much is online nursing school? Tuition rates vary, but selecting an affordable option can help reduce student debt. For those looking to advance their careers, the cheapest online fnp program can lead to becoming a Family Nurse Practitioner, a highly-respected role in today’s healthcare landscape.

Nurses aiming for higher credentials should also consider doctorate in nursing education online programs. These programs are designed for those interested in teaching or leadership roles. Registered Nurses can bridge their credentials with the cheapest rn to bsn program, making career progression more affordable and accessible than ever before.

Best Scientists Citing Matthew T. Roe

Trending Scientists

Recently Published Articles